Latest News & Features
Americas
Biopharmaceutical company Omeros has hit its competitor Par Pharmaceutical with two lawsuits at US district courts over the drug company’s attempt to market a generic version of its Omidria product. 7 September 2015
Americas
Drug maker Sandoz has officially launched its Zarxio biosimilar after a US appeals court declined to issue an injunction that would have prevented it from being sold. 4 September 2015
Americas
Hedge fund manager Kyle Bass’s Coalition for Affordable Drugs has suffered another setback in its bid to knock out allegedly spurious patents after the US Patent and Trademark Office declined to institute an inter partes review of a patent owned by Biogen. 3 September 2015
Americas
A group of 23 law professors has urged the US Court of Appeals for the Federal Circuit to re-hear the Ariosa v Sequenom dispute en banc. 2 September 2015
Americas
Hedge fund manager Kyle Bass’s group the Coalition for Affordable Drugs has targeted two patents owned by the University of Pennsylvania in the latest petition for an inter partes review. 1 September 2015
Americas
The US Food and Drug Administration has proposed using four-letter suffixes to name biosimilar drugs. 1 September 2015
Americas
US pharmaceutical company Eli Lilly has thwarted attempts by its competitors to market a generic version of its Alimta (pemetrexed) drug. 27 August 2015
Americas
Pfizer’s buyout of Hospira, which is set to boost Pfizer’s biosimilars portfolio but has been the subject of anti-competition concerns, will be completed next month after gaining final approval. 26 August 2015
Americas
Hedge fund manager Kyle Bass has been dealt a blow after failing to invalidate two patents owned by biotechnology company Acorda Therapeutics. 25 August 2015
Americas
Sandoz, Allergan and Accord Healthcare have demonstrated “clear and convincing” evidence that a patent owned by Millennium Pharmaceuticals and used in its Velcade cancer treatment drug is invalid, according to a US court ruling. 24 August 2015